Compare UBCP & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | UBCP | FBIO |
|---|---|---|
| Founded | 1902 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 91.6M | 90.7M |
| IPO Year | 1995 | 2011 |
| Metric | UBCP | FBIO |
|---|---|---|
| Price | $16.00 | $2.55 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $17.00 |
| AVG Volume (30 Days) | 4.9K | ★ 308.3K |
| Earning Date | 05-08-2026 | 05-15-2026 |
| Dividend Yield | ★ 5.73% | N/A |
| EPS Growth | 5.51 | ★ 97.40 |
| EPS | 0.69 | ★ 2.86 |
| Revenue | N/A | ★ $63,262,000.00 |
| Revenue This Year | N/A | $55.22 |
| Revenue Next Year | $5.58 | $40.55 |
| P/E Ratio | $22.80 | ★ $0.88 |
| Revenue Growth | N/A | ★ 9.69 |
| 52 Week Low | $12.55 | $2.18 |
| 52 Week High | $17.34 | $4.53 |
| Indicator | UBCP | FBIO |
|---|---|---|
| Relative Strength Index (RSI) | 55.61 | 38.36 |
| Support Level | $14.91 | $2.19 |
| Resistance Level | $16.03 | $3.02 |
| Average True Range (ATR) | 0.28 | 0.09 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 100.00 | 33.53 |
United Bancorp Inc operates as a bank holding company that provides commercial and retail banking services. Through its subsidiary (Unified Bank), the company provides a broad range of banking and financial services, which include accepting demand, savings, and time deposits and granting commercial, real estate, and consumer loans. The Company's primary deposit products are checking, savings, and term certificate accounts, and its primary lending products are residential mortgage, commercial, and installment loans. The bank also operates in Marshall County, West Virginia.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.